Your browser doesn't support javascript.
loading
Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma.
Trasanidis, Nikolaos; Katsarou, Alexia; Ponnusamy, Kanagaraju; Shen, Yao-An; Kostopoulos, Ioannis V; Bergonia, Bien; Keren, Keren; Reema, Paudel; Xiao, Xiaolin; Szydlo, Richard M; Sabbattini, Pierangela M R; Roberts, Irene A G; Auner, Holger W; Naresh, Kikkeri N; Chaidos, Aristeidis; Wang, Tian-Li; Magnani, Luca; Caputo, Valentina S; Karadimitris, Anastasios.
Afiliação
  • Trasanidis N; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Katsarou A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Ponnusamy K; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Foundation Trust, London, United Kingdom.
  • Shen YA; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Kostopoulos IV; Department of Pathology.
  • Bergonia B; Department of Oncology.
  • Keren K; Department of Gynecology and Obstetrics, and.
  • Reema P; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Xiao X; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Szydlo RM; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Sabbattini PMR; Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece.
  • Roberts IAG; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Auner HW; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Naresh KN; Imperial Experimental Cancer Medicine Centre and Cancer Research UK Imperial Centre, London, United Kingdom.
  • Chaidos A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Wang TL; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Magnani L; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Caputo VS; Department of Paediatrics and Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Oxford University, Oxford, United Kingdom.
  • Karadimitris A; Oxford Biomedical Research Centre Blood Theme, National Institute for Health Research Oxford Biomedical Centre, Oxford, United Kingdom.
Blood ; 139(13): 1939-1953, 2022 03 31.
Article em En | MEDLINE | ID: mdl-35015835

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos